76391-34-9: Enalapril EP Impurity F

Enalapril EP Impurity F (CAS No.76391-34-9) is a prodrug that is hydrolyzed after absorption to form the active angiotensin-converting enzyme Enalaprilat. It is administered orally. It decreases blood pressure by lowering peripheral resistance without increasing heart rate. It is well tolerated and safe.

Additional information

Catalogue No.

VL1360006

CAS No.

76391-34-9

Molecular Formula

C22H33ClN2O5

Molecular Weight

440.96

IUPAC Name

(2S)-1-[(2S)-2-[[(1S)-1-(Butoxycarbonyl)-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid hydrochloride

Synonyms

Enalapril Butyl Ester Analog

References

Sax, Paul E., et al. “Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Dolutegravir with Emtricitabine and Tenofovir Alafenamide, for Initial Treatment of HIV-1 Infection (GS-US-380–1490): A Randomised, Double-Blind, Multicentre, Phase 3, Non-Inferiority Trial.” The Lancet, vol. 390, no. 10107, Nov. 2017, pp. 2073–82, https://doi.org/10.1016/s0140-6736(17)32340-1.
Bang, Lynne M., and Lesley J. Scott. “Emtricitabine.” Drugs, vol. 63, no. 22, 2003, pp. 2413–24, https://doi.org/10.2165/00003495-200363220-00003.

Status

In-stock